5-Jun-2026 - The Globe and Mail Goldman Sachs Reaffirms Their Buy Rating on Merck & Company (MRK) Goldman Sachs analyst Asad Haider maintained a Buy rating on Merck & Company on June 2 and set a price target of $137.00. The company’s shares closed yesterday at $115.65. Claim ...
3-Jun-2026 - 24/7 Wall St Pfizer vs Merck: Chasing High Yield vs Higher Returns PFE yields 6.58% at a forward P/E of 9, while MRK surged 61% over the past year with a far smaller payout. KEYTRUDA drives roughly half of Merck's pharma revenue, making its biosimilar patent cliff ...
3-Jun-2026 - The Globe and Mail Bernstein Remains a Hold on Merck & Company (MRK) Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company yesterday. The company’s shares closed yesterday at $115.17. Claim 55% Off TipRanks. Unlock trusted, ...
2-Jun-2026 - The Globe and Mail Barclays Reaffirms Their Buy Rating on Merck & Company (MRK) Barclays analyst Emily Field maintained a Buy rating on Merck & Company today and set a price target of $140.00. Claim 55% Off TipRanks. Unlock trusted, data-backed investing tool ...
5-Jun-2026 - The Globe and Mail Goldman Sachs Reaffirms Their Buy Rating on Merck & Company (MRK) Goldman Sachs analyst Asad Haider maintained a Buy rating on Merck & Company on June 2 and set a price target of $137.00. The company’s shares closed yesterday at $115.65. Claim ...
3-Jun-2026 - 24/7 Wall St Pfizer vs Merck: Chasing High Yield vs Higher Returns PFE yields 6.58% at a forward P/E of 9, while MRK surged 61% over the past year with a far smaller payout. KEYTRUDA drives roughly half of Merck's pharma revenue, making its biosimilar patent cliff ...
3-Jun-2026 - The Globe and Mail Bernstein Remains a Hold on Merck & Company (MRK) Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company yesterday. The company’s shares closed yesterday at $115.17. Claim 55% Off TipRanks. Unlock trusted, ...
2-Jun-2026 - The Globe and Mail Barclays Reaffirms Their Buy Rating on Merck & Company (MRK) Barclays analyst Emily Field maintained a Buy rating on Merck & Company today and set a price target of $140.00. Claim 55% Off TipRanks. Unlock trusted, data-backed investing tool ...
